Wednesday 6-25-2014 Vertex Pharmaceuticals Inc (VRTX) $VRTX opened at 92.26 hitting the high price of 93.35 and a day low of 89.27 with a total volume of 7,001,292. VRTX had a previous close of 93.53 and has been seeing an average volume of 3,030,010.
Overall Average: 72% Buy
Recent stock forum discussions about VRTX http://investorshangout.com/search?q=VRTX&...mp;yt0=Go!
Why Valero Energy Corporation, Phillips 66, and Vertex Pharmaceuticals Incorporated Are Today's 3 Wo
John Divine, The Motley Fool - Motley Fool - 8 mins ago
Today investors learned that the U.S. economy was absolutely abysmal in the first quarter of 2014. Far exceeding even the most bearish estimates, gross domestic product actually contracted by 2.9% in the January-March period, the steepest setback... (full story)
Mad About Missing Vertex Pharma's Big Move? Don't Be, The Stock Is Still Undervalued
at The Street - Wed Jun 25, 10:26AM CDT
Investors aren't yet recognizing Vertex's ability to develop triple-combo therapies for hardest-to-treat cystic fibrosis patients. (full story)
Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 9:45AM CDT
Vertex Pharmaceuticals Incorporated (VRTX) was up a whopping 40.41% on Jun 24, 2014, after the company announced positive results from two phase III studies. (full story)
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver
PR Newswire - Wed Jun 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for VRTX, DLTR, CAR, R, and BIIB. (full story)
Will These Analyst Moves Affect Vertex Pharmaceuticals (VRTX) Stock Today?
at The Street - Wed Jun 25, 8:08AM CDT
A pair of analysts took action on Vertex Pharmaceuticals (VRTX) on Wednesday. (full story)
Downgrade Alert for Vertex Pharmaceuticals (VRTX)
Comtex SmarTrend(R) - Wed Jun 25, 7:57AM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $93.53 on volume of 25.2 million shares, above average daily volume of 1.5 million. Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases. (full story)
Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:44AM CDT
Vertex Pharmaceuticals Incorporated (VRTX) was a big mover last session, as the company saw its shares catapult over a whopping 40% on the day. (full story)
Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity
PR Newswire - Wed Jun 25, 7:15AM CDT
Biotech sector sees progress as companies develop advanced cancer therapeutics resulting in significant clinical data; company reaches agreement to develop drug aiding cancer treatment: GenSpera, Inc. (OTC: GNSZ), Seattle Genetics Inc. (NASDAQ: SGEN), (Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), OXiGENE, Inc. (NASDAQ: OXGN) and MerriMack Pharmaceuticals, Inc. (NASDAQ: MACK) (full story)
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off. (full story)
Vertex's Price Pop by the Numbers: Does It Fly?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Tue Jun 24, 8:44PM CDT
U.S. stocks finished lower on Tuesday, with the benchmark S&P 500 closing down 0.6%, while the narrower Dow Jones Industrial Average lost 0.7%. The technology-heavy Nasdaq Composite Index fell 0.1%. One Nasdaq component had a banner day,... (full story)
Vertex Gets Out of TRAFFIC and TRANSPORTs Shares 40% Higher
Brian Orelli, The Motley Fool - Motley Fool - Tue Jun 24, 6:01PM CDT
Sometimes good enough really is good enough. But only if you're treating the right patient population. Vertex Pharmaceuticals seems to be really good at picking them. The biotech gets a passing grade for improving lung function in its clinical... (full story)
What Does Today's Pop Mean for Vertex?
Mark Reeth, Morgan Housel, and Michael Olsen, CFA, The Motley Fool - Motley Fool - Tue Jun 24, 5:58PM CDT
On Tuesday's MarketFoolery , host Mark Reeth, along with Million Dollar Portfolio analyst Michael Olsen, and Motley Fool One analyst Morgan Housel, discuss Vertex 's recent jump. After two cystic fibrosis trials finished with strong results,... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Nasdaq stocks posting largest percentage increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: (full story)
Most active Nasdaq-traded stocks
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Why Vertex Pharmaceuticals, InnerWorkings, and SINA Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Jun 24, 4:15PM CDT
If you're a pessimist the past couple of years haven't given you much to cheer about; but today's move lower in the S&P 500 just might be a start. Overall, today's economic data releases were generally positive and wouldn't have been... (full story)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX
PR Newswire - Tue Jun 24, 3:56PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals Incorporated ("Vertex" or the "Company"
(NasdaqGS: VRTX) securities between May 7, 2012 and May 29, 2012. (full story)
What Had the Dow in the Dumps Today?
Alex Planes, The Motley Fool - Motley Fool - Tue Jun 24, 3:49PM CDT
The Dow Jones Industrial Average today was smacked by i ts worst one-day decline in a month after starting trading in narrowly positive territory. The fact that the worst decline in a month only amounts to 0.7% -- the Dow fell by 0.8% on May 20... (full story)
Up 40%: Is Vertex's Surge Justified?
Todd Campbell, The Motley Fool - Motley Fool - Tue Jun 24, 3:32PM CDT
Vertex has been one of the most hit-and-miss investments in the biotech industry over the past five years, but investors who have hung in through thick and thin have been rewarded. Despite a short-lived run as the globe's pre-eminent leader in... (full story)
Walgreen and Vertex are big market movers
AP - Tue Jun 24, 3:25PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market: (full story)
Overall Average: 72% Buy
Recent stock forum discussions about VRTX http://investorshangout.com/search?q=VRTX&...mp;yt0=Go!
Why Valero Energy Corporation, Phillips 66, and Vertex Pharmaceuticals Incorporated Are Today's 3 Wo
John Divine, The Motley Fool - Motley Fool - 8 mins ago
Today investors learned that the U.S. economy was absolutely abysmal in the first quarter of 2014. Far exceeding even the most bearish estimates, gross domestic product actually contracted by 2.9% in the January-March period, the steepest setback... (full story)
Mad About Missing Vertex Pharma's Big Move? Don't Be, The Stock Is Still Undervalued
at The Street - Wed Jun 25, 10:26AM CDT
Investors aren't yet recognizing Vertex's ability to develop triple-combo therapies for hardest-to-treat cystic fibrosis patients. (full story)
Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 9:45AM CDT
Vertex Pharmaceuticals Incorporated (VRTX) was up a whopping 40.41% on Jun 24, 2014, after the company announced positive results from two phase III studies. (full story)
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver
PR Newswire - Wed Jun 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for VRTX, DLTR, CAR, R, and BIIB. (full story)
Will These Analyst Moves Affect Vertex Pharmaceuticals (VRTX) Stock Today?
at The Street - Wed Jun 25, 8:08AM CDT
A pair of analysts took action on Vertex Pharmaceuticals (VRTX) on Wednesday. (full story)
Downgrade Alert for Vertex Pharmaceuticals (VRTX)
Comtex SmarTrend(R) - Wed Jun 25, 7:57AM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $93.53 on volume of 25.2 million shares, above average daily volume of 1.5 million. Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases. (full story)
Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:44AM CDT
Vertex Pharmaceuticals Incorporated (VRTX) was a big mover last session, as the company saw its shares catapult over a whopping 40% on the day. (full story)
Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity
PR Newswire - Wed Jun 25, 7:15AM CDT
Biotech sector sees progress as companies develop advanced cancer therapeutics resulting in significant clinical data; company reaches agreement to develop drug aiding cancer treatment: GenSpera, Inc. (OTC: GNSZ), Seattle Genetics Inc. (NASDAQ: SGEN), (Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), OXiGENE, Inc. (NASDAQ: OXGN) and MerriMack Pharmaceuticals, Inc. (NASDAQ: MACK) (full story)
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off. (full story)
Vertex's Price Pop by the Numbers: Does It Fly?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Tue Jun 24, 8:44PM CDT
U.S. stocks finished lower on Tuesday, with the benchmark S&P 500 closing down 0.6%, while the narrower Dow Jones Industrial Average lost 0.7%. The technology-heavy Nasdaq Composite Index fell 0.1%. One Nasdaq component had a banner day,... (full story)
Vertex Gets Out of TRAFFIC and TRANSPORTs Shares 40% Higher
Brian Orelli, The Motley Fool - Motley Fool - Tue Jun 24, 6:01PM CDT
Sometimes good enough really is good enough. But only if you're treating the right patient population. Vertex Pharmaceuticals seems to be really good at picking them. The biotech gets a passing grade for improving lung function in its clinical... (full story)
What Does Today's Pop Mean for Vertex?
Mark Reeth, Morgan Housel, and Michael Olsen, CFA, The Motley Fool - Motley Fool - Tue Jun 24, 5:58PM CDT
On Tuesday's MarketFoolery , host Mark Reeth, along with Million Dollar Portfolio analyst Michael Olsen, and Motley Fool One analyst Morgan Housel, discuss Vertex 's recent jump. After two cystic fibrosis trials finished with strong results,... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Nasdaq stocks posting largest percentage increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: (full story)
Most active Nasdaq-traded stocks
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Why Vertex Pharmaceuticals, InnerWorkings, and SINA Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Jun 24, 4:15PM CDT
If you're a pessimist the past couple of years haven't given you much to cheer about; but today's move lower in the S&P 500 just might be a start. Overall, today's economic data releases were generally positive and wouldn't have been... (full story)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX
PR Newswire - Tue Jun 24, 3:56PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals Incorporated ("Vertex" or the "Company"
(NasdaqGS: VRTX) securities between May 7, 2012 and May 29, 2012. (full story) What Had the Dow in the Dumps Today?
Alex Planes, The Motley Fool - Motley Fool - Tue Jun 24, 3:49PM CDT
The Dow Jones Industrial Average today was smacked by i ts worst one-day decline in a month after starting trading in narrowly positive territory. The fact that the worst decline in a month only amounts to 0.7% -- the Dow fell by 0.8% on May 20... (full story)
Up 40%: Is Vertex's Surge Justified?
Todd Campbell, The Motley Fool - Motley Fool - Tue Jun 24, 3:32PM CDT
Vertex has been one of the most hit-and-miss investments in the biotech industry over the past five years, but investors who have hung in through thick and thin have been rewarded. Despite a short-lived run as the globe's pre-eminent leader in... (full story)
Walgreen and Vertex are big market movers
AP - Tue Jun 24, 3:25PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market: (full story)
